Showing 1 - 8 of 8
Persistent link: https://www.econbiz.de/10010848991
Persistent link: https://www.econbiz.de/10005204358
The prevalence of cancer is set to increase sharply with new pressures for change in treatment and prevention. This paper reviews evidence on likely changes in treatment costs, which will increase with improved survival, and on the distribution of costs to society. It then presents a profile of...
Persistent link: https://www.econbiz.de/10005142308
Palliative care has been through a difficult development process, but now has the evidence and experience base to make a contribution in the changing health environment. There has now been a great deal of experience with different types of care, and research has shown that patients strongly...
Persistent link: https://www.econbiz.de/10005448919
The most well established antithrombotic treatment for acute coronary syndromes (ACS) is unfractionated heparin (UFH) plus aspirin, but such treatment may not prevent arterial thrombotic events. Low molecular weight heparins (LMWHs) and platelet glycoprotein (GP) IIb/IIIa inhibitors offer...
Persistent link: https://www.econbiz.de/10005404971
Alzheimer's disease is one of several diseases of the elderly that has recently come into prominence for a number of reasons. First, its prevalence is set to increase as a result of the aging of Western populations. Secondly, the use of institutional care has fallen as a result of major policy...
Persistent link: https://www.econbiz.de/10005590338
Persistent link: https://www.econbiz.de/10010715436
Persistent link: https://www.econbiz.de/10005516195